Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOBENZAPRINE Cause Ischaemic hepatitis? 7 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Ischaemic hepatitis have been filed in association with CYCLOBENZAPRINE (Cyclobenzaprine hydrochloride). This represents 0.1% of all adverse event reports for CYCLOBENZAPRINE.

7
Reports of Ischaemic hepatitis with CYCLOBENZAPRINE
0.1%
of all CYCLOBENZAPRINE reports
1
Deaths
7
Hospitalizations

How Dangerous Is Ischaemic hepatitis From CYCLOBENZAPRINE?

Of the 7 reports, 1 (14.3%) resulted in death, 7 (100.0%) required hospitalization, and 1 (14.3%) were considered life-threatening.

Is Ischaemic hepatitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOBENZAPRINE. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOBENZAPRINE Cause?

Toxicity to various agents (1,854) Pain (1,494) Completed suicide (1,438) Drug hypersensitivity (1,094) Constipation (1,057) Drug ineffective (954) Drug abuse (873) Off label use (800) Fall (796) Hypotension (769)

What Other Drugs Cause Ischaemic hepatitis?

FUROSEMIDE (46) METFORMIN (36) ACETAMINOPHEN (33) AMIODARONE (29) REMDESIVIR (29) OXYCODONE (28) HEPARIN (26) VENLAFAXINE (23) DOXORUBICIN (22) IBUPROFEN (21)

Which CYCLOBENZAPRINE Alternatives Have Lower Ischaemic hepatitis Risk?

CYCLOBENZAPRINE vs CYCLOPENTOLATE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE

Related Pages

CYCLOBENZAPRINE Full Profile All Ischaemic hepatitis Reports All Drugs Causing Ischaemic hepatitis CYCLOBENZAPRINE Demographics